Maraviroc Efficacy for Hepatitis C

Summary

This is a single-site, longitudinal, open-label, interventional study for evaluating the effect of maraviroc on hepatitis C viral levels in patients infected with both hepatitis C and human immunodeficiency virus (HIV) and taking antiretroviral therapy for HIV.

Timeline

Start

2017-06-01

Primary completion

2019-03-27

Completion

2019-03-27

Drugs

Indications